CPC C09D 177/04 (2013.01) [A61F 2/02 (2013.01); A61L 27/04 (2013.01); A61L 27/34 (2013.01); A61L 27/54 (2013.01); A61L 27/58 (2013.01); B05D 7/58 (2013.01); C09D 105/04 (2013.01); C09D 167/04 (2013.01); A61F 2210/0076 (2013.01); A61F 2310/00976 (2013.01); A61L 2300/608 (2013.01); A61L 2420/08 (2013.01)] | 15 Claims |
1. A coated medical implant device, comprising:
a substrate selected from the group comprising magnesium metal, magnesium alloy, iron metal, iron alloy, ferrous metal and ferrous alloy;
a pretreatment agent selected from the group consisting of alkali metal hydroxide, hydrogen fluoride, alkali metal carbonates, and mixtures thereof, applied to a surface of the substrate to form a charged substrate having a positive charge or a negative charge;
a polyelectrolyte multilayer coating deposited on the charged substrate, comprising:
a plurality of interfacing, individual polymer layers, comprising:
at least one polymer layer comprising a first polymer and having a positive charge; and
at least one polymer layer comprising a second polymer and having a negative charge;
wherein an initial polymer layer of the plurality of interfacing, individual polymer layers is deposited on the charged substrate and has a charge opposite the charged substrate, and
wherein an outer polymer layer of the plurality of interfacing, individual polymer layers forms an exterior surface of the charged substrate;
fibronectin immobilized on the exterior surface; and
an active substance, in addition to the fibronectin, deposited on the exterior surface of the charged substrate.
|